Clinical Trials
Clinical Trials
Information on Landos Biopharma’s studies of omilancor (BT-11) and NX-13 are available at ClinicalTrials.gov.
| Drug | Study Phase |
|---|---|
| Omilancor | Global Phase 2 Ulcerative Colitis study |
| Omilancor | Global Phase 2 Crohn’s disease study |
| NX-13 | Global Phase 1b Ulcerative Colitis study |
